Q Fever

Q Fever

Q Fever is an infectious disease caused by coxiella burneti. This bacteria is naturally present in some animals including cattle, goats and sheep. Coxiella burnet bacteria are found in the birth products (placenta, amminotic fluids) and in the body secretions such as urine, faecal matter and milk of infected animals. This is a communicable disease and can be transmitted from infected animals to the human being through contaminated dust particles. High-risk occupations including farming, veterinarian doctors and researchers are more susceptible to getting Q fever. Symptoms of Q fever include chills, cough, fever and nausea. Q fever is treated with antibiotics.

The Q Fever Market is anticipated to grow with the CAGR of 5% in the forecasted period.

The rising prevalence of Q fever disease is driving the market growth for Q fever globally. For instance, according to the Centre for Disease and Control, 2021 report, In 2019, around 178 cases of acute Q fever were reported and approximately 34 cases of chronic Q fever. Additionally, high-risk occupations such as agriculture, farmers, veteran doctors and animal researchers are at a higher risk of exposure to the bacteria. Further, people with low immunity or compromised immunity are at a higher risk to develop Q fever in the near future. Thus, these above-mention elements are anticipated to boost the market for Q fever in the forecasting period.

• Based on the type the Q fever market is bifurcated into acute Q fever and chronic Q fever. Among these, the acute Q fever segment is anticipated to grow with a significant CAGR in the forecasted period. This is attributed to the rising prevalence of acute Q fever cases on contrary to chronic. For instance, according to the Centre for Disease and Control, 2021 report, In 2019, around 178 cases of acute Q fever cases were reported in the united states. Thus, with the rising incidence of acute Q fever, this segment is anticipated to grow significantly.
• Based on the medication the market is segmented into antibiotics, antimalarial, corticosteroids and others. Amongst these, the antibiotics segment is anticipated to grow with a significant CAGR. antibiotics are effective in treating the bacterial infections that can occur as a result of Q fever. Antibiotics can help to reduce symptoms and shorten the duration of the illness, and thus is a preferred choice of drug.
• Based on end-users the market is segmented into hospitals, clinics and research institutes. Amongst these, the hospital segment is anticipated to grow with a significant CAGR in the forecasted period. Hospitals play a crucial role in the early detection and management of Q Fever infections, which can help prevent severe complications and reduce the overall burden of the disease on the healthcare system. Thus, this factor is driving the demand for the hospitals
• For a better understanding of the market adoption of the Behavior Health industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (UK, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Rest of World. Asia-pacific is anticipated to grow with a significant CAGR during the forecasted period. India is an agricultural hub with a sector contributing significantly to countries economy and employment. Additionally in areas where large no. animals such as cattle, buffalo and sheep. These animals can serve as a reservoir for the Coxiella burnet. To control the spread of Q fever in the agriculture sector the government would take certain initiatives to educate people for spreading awareness regarding the disease.
• Some of the major players operating in the market include Sun Pharmaceutical Industries Ltd., Abbott., Aurobindo Pharma., Pfizer Inc., lupin, Bayers AG, Novartis Pharmaceutical Corporation, GSK plc., Merck & Co.,Inc., Sanofi.